Physician profile
Michael Murphy
NPI 1538629746
$18,010.26
in general payments reported to CMS, 2019-2025
9 companies · $5,755 in 2025
The $5,755 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,318 · 2020: $19.67 · 2021: $1,647 · 2022: $121 · 2023: $556 · 2024: $5,593 · 2025: $5,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Travel and Lodging: $4,017 · Food and Beverage: $2,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Travel and Lodging | $4,016.75 |
| Food and Beverage | $2,887.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,823.75 | 2019-2025 | Real Intelligence, Ri Hip Navigation, Journey II |
| Medical Device Business Services, INC. | $6,738.30 | 2019-2025 | Actis, Attune |
| Depuy Synthes Sales INC. | $1,236.10 | 2019-2025 | Na, Attune, Acf |
| Linkbio Corp | $1,183.10 | 2025 | |
| Microport Orthopedics INC | $959.86 | 2025 | Mpo Medial Pivot Knee |
| Stryker Corporation | $649.08 | 2019-2025 | Mako, Triathlon, Insignia |
| Integra Lifesciences Corporation | $188.19 | 2023 | Tenoglide |
| Medacta USA, INC. | $185.32 | 2025 | Gmk Sphere |
| Medwest Associates | $46.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.